Glenmede Trust CO Na Zynerba Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.27 - $4.64 $163 - $231	-50 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$7.98 - $12.39 $1,596 - $2,478	-200 Reduced 80.0%	50 $0
Q4 2017 Feb 15, 2018	SELL	$8.69 - $14.59 $2,607 - $4,377	-300 Reduced 54.55%	250 $3,000
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $3,151 - $5,192	550	550 $0

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.